MedTech and In Vitro Diagnostic Co-operatives
Following the announcement made by the Minister for Public Health and Innovation at NHS Expo earlier this year, a competition for NIHR Medtech and In vitro diagnostic Co-operative (NIHR MIC) funding is underway.
The scheme aims to provide NIHR research infrastructure funding for NHS Organisations to act as centres of expertise for the development of medical technologies and/or the generation of high-quality evidence on commercially-supplied IVDs.
It is envisaged that the NIHR MICs will be designated and funded to:
- catalyse NHS “pull” to develop new concepts, demonstrate proof of principle and devise research protocols for new medical devices, healthcare technologies or technology-dependent interventions that are applicable across the NHS. This will address clinical areas or themes of high morbidity and unmet need for NHS patients and healthcare technology users, which have not benefited from a high degree of innovation, including paediatrics which is being highlighted as being of particular strategic importance.
- catalyse the generation of evidence on commercially-supplied IVDs that is required by the NHS, industry and a range of users including accredited providers of NHS pathology services and NICE. This will focus on clinical areas or themes where evidence of the clinical validity, clinical utility, cost-effectiveness and care pathway benefits of IVDs has the potential to lead to improvements in healthcare services and the quality of life of NHS patients.
- address a combination of these two aspects.
Funding of around £14m will be invested over a five-year period from 1 January 2018 depending on receipt of suitable quality applications.
The closing date for submission of a full application was 25 January 2017 at 13:00.
Full Application Guidance - available here.
The FAQ document to support the Full Application Guidance is available here.
Word version of the application - available here.
Any questions should be submitted to Cassie Zwier (email@example.com) at NIHR CCF.